California Pacific Medical Center Research Institute’s Institutional Biosafety Committee (IBC) oversees research at the institute. The National Institutes of Health considers IBCs to be "the cornerstone of institutional oversight of recombinant DNA research". Committee members review any recombinant DNA studies to be carried out here and ensure they are conducted according to the NIH Guidelines.

Please direct IBC questions, form requests, and completed forms to:
Angeline Monton
angeline.monton@sutterhealth.org

Submission and Meeting Dates

The CPMC IBC committee meets monthly online. Meetings are on Thursdays, 12:15 pm – 1:15 pm.

IBC Guidelines for Research Involving Recombinant DNA Molecules

• NIH Guidelines for Research Involving Recombinant DNA Molecules